APIM Therapeutics
Phase 1APIM Therapeutics. Disabling Cancer's Ability to Escape Treatment
Founded
2017
Focus
RNA & Gene Therapy
About
APIM Therapeutics. Disabling Cancer's Ability to Escape Treatment
Funding History
2Total raised: $4.7M
Grant$1.5MResearch Council of NorwayMay 15, 2021
Seed$3.2MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2017
LocationOslo, Norway
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Algipharma
Phase 1 · Bergen
Bio-Me
Pre-clinical · Oslo
CardiNor
Pre-clinical · Oslo
Gentian USA
Pre-clinical · Moss
Hemispherian
Phase 1 · Oslo
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile